Medical WEIGHT LOSS

---

Medical weight loss is a personalized, science-backed approach designed to help individuals achieve sustainable weight loss utilizing peptides to do so. These peptides include a combination of GLP-1, GIP and Glucagon.

What is the difference between GLP1 semaglutide and GLP1/ GIP tirzepatide?

Trizepatide is a dual glucose-dependent insulinotropic polypeptide–GLP-1 receptor agonist. This means this medication works on two different receptors, GIP and GLP-1. The GIP receptors are activated to improve insulin sensitivity, insulin secretion, satiety (feeling full), and the body's ability to burn fat (lipolysis). Simultaneously, the GLP-1 receptors are stimulated to decrease glucagon secretion, slow gastric emptying, and decrease appetite. Concurrent action on both GIP and GLP-1 produces weight loss, lowered cholesterol, and reduced cardiovascular risk for patients.